ANA GOMEZ-VAZQUEZ: Open Payments
NPI 1548049513 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,564 in 106 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $772 · 2025 $2,564
Food & beverage: $2,396Education: $168
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $371 |
| Regeneron Healthcare Solutions, Inc. | 21 | $343 |
| UCB, Inc. | 9 | $318 |
| PFIZER INC. | 11 | $264 |
| Novartis Pharmaceuticals Corporation | 9 | $205 |
| GENZYME CORPORATION | 8 | $186 |
| Lilly USA, LLC | 5 | $169 |
| Arcutis Biotherapeutics, Inc. | 9 | $149 |
| ABBVIE INC. | 4 | $108 |
| Incyte Corporation | 5 | $103 |
Products named: DUPIXENT, TREMFYA, Bimzelx, CIBINQO, Zoryve, OPZELURA, OTEZLA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
